Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Myriad Genetics Inc (MYGN)

201 + Investors. Track Smart Money conviction in MYGN. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -16
Streak
1Q ▼
Buyers last Q
48%

Smart Money Signals — MYGN

Based on 202 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their MYGN positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 84% of 3.0Y peak

84% of all-time peak
202 funds currently hold this stock — 84% of the 3.0-year high of 241 funds (reached 2024 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 12% fewer funds vs a year ago

fund count last 6Q
27 fewer hedge funds hold MYGN compared to a year ago (-12% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 48% buying

107 buying115 selling
Last quarter: 115 funds reduced or exited vs 107 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~32 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 41 → 41 → 34 → 32. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

66% of holders stayed for 2+ years

■ 66% conviction (2yr+) ■ 18% medium ■ 16% new
133 out of 202 hedge funds have held MYGN for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +131%, value -11%

Value
-11%
Shares
+130%
Last quarter: funds added +131% more shares while total portfolio value only changed -11%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

43 → 41 → 41 → 34 → 32 new funds/Q
New funds entering each quarter: 41 → 41 → 34 → 32. MYGN is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 72% veterans vs 20% newcomers

■ 72% veterans ■ 9% 1-2yr ■ 20% new
Entry-cohort mix of 204 holders: 146 (72%) are 2+ year veterans, 18 entered 1–2 years ago, and 40 (20%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds
46 of 202 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.7
out of 10
Low Exit Risk
Exit risk score 2.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — MYGN

In 2026 Q1, 107 hedge funds were net buyers of MYGN (32 opened a new position, 75 added to an existing one), while 115 reduced or exited (67 trimmed, 48 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 34% of total institutional value in MYGN is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -16 funds (more exits than new entries). Total institutional holders: 202.

Hedge Fund Ownership: MYGN

How many hedge funds hold MYGN — quarterly history vs. share price
Quarterly hedge fund ownership of MYGN vs. share price

Market Analysis: MYGN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: MYGN

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Myriad Genetics Inc (MYGN) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much MYGN has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
MYGN
-4.0%
XLV
+4.5%

MYGN outperformed XLV by -8.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
MYGN
+20.7%
XLV
+5.6%

Since the filing became public, MYGN outperformed XLV by +15.1% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 0 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
0.2
/ 10
conviction
Hedge Fund Positioning: MYGN
201 + Investors

Track Smart Money conviction in MYGN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 201 218 -7.8%
13F Shares 213M 92M 130.72%
Total Value $504M $566M -11.07%
New Positions 31 34 -3
Increased Positions 75 84 -9
Closed Positions 48 29 +19
Reduced Positions 66 73 -7
Total Calls 1 1 -
Total Puts 1 0 100%
PUT/CALL Ratio 1.0 0.0 Neutral

Statistics: MYGN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

201 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MYGN. Verified SEC 13F-HR filings.

QUARTER:
Top 25 MYGN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Glenview Capital Management, LLC 0.61% 5,411,978 $24.4M
2 Vestal Point Capital, LP 0.21% 1,648,000 $7.4M
3 Y-Intercept (Hong Kong) Ltd 0.06% 654,224 $2.9M
4 Headlands Technologies LLC 0.05% 105,414 $474K
5 AIMZ Investment Advisors, LLC 0.05% 37,210 $167K
6 Oxford Asset Management LLP 0.05% 25,309 $114K
7 Scientech Research LLC 0.05% 12,377 $56K
8 Inspire Investing, LLC 0.04% 115,726 $521K
9 Virtus Advisers, LLC 0.04% 20,000 $90K
10 Jacobs Levy Equity Management, Inc 0.04% 2,088,492 $9.4M
11 State of Wyoming 0.03% 62,664 $282K
12 Axq Capital, LP 0.03% 45,127 $203K
13 Catalyst Funds Management Pty Ltd 0.03% 33,980 $153K
14 Susquehanna Portfolio Strategies, LLC 0.02% 364,154 $1.6M
15 Hrt Financial LP 0.02% 1,786,319 $8.0M
16 Moore Capital Management, LP 0.02% 218,398 $983K
17 Martingale Asset Management L P 0.02% 165,427 $744K
18 Federated Hermes, INC. 0.01% 1,976,166 $8.9M
19 Connor, Clark & Lunn Investment Management Ltd. 0.01% 1,318,663 $5.9M
20 Voleon Capital Management LP 0.01% 137,241 $618K
21 Weiss Asset Management LP 0.01% 174,844 $787K
22 Trexquant Investment LP 0.01% 406,102 $1.8M
23 Millennium Management LLC 0.01% 6,668,817 $30.0M
24 D. E. Shaw & Co., Inc. 0.01% 4,499,724 $20.2M
25 Assenagon Asset Management S.A. 0.01% 1,446,961 $6.5M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Myriad Genetics Inc (MYGN)

What does the Smart Money Trend signal show for MYGN?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their MYGN positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for MYGN?

More sellers than buyers — 48% buying: Last quarter: 115 funds reduced or exited vs 107 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for MYGN holders?

Strong quality — 34% AUM from major funds: 46 of 202 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held MYGN?

66% of holders stayed for 2+ years: 133 out of 202 hedge funds have held MYGN for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Myriad Genetics Inc (MYGN) following the 2026 Q1 hedge fund 13F filings?

As of today, MYGN has moved +20.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.6% for the XLV sector ETF — an outperformance of +15.1%. Since the quarter end (March 31, 2026), MYGN has gained -4.0% vs +4.5% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →